High expression of antioxidant proteins in dendritic cells: possible
  implications in atherosclerosis by Rivollier, Aymeric et al.
1/23
High expression of antioxidant proteins in dendritic cells :
possible implications in atherosclerosis
Aymeric Rivollier1, Laure Perrin-Cocon1, Sylvie Luche2, Hélène Diemer3, Jean-Marc Strub3, Daniel
Hanau4, Alain van Dorsselaer3, Vincent Lotteau1, Chantal Rabourdin-Combe1 ,Thierry Rabilloud2 and
Christine Servet-Delprat1
1 INSERM U503, Université Lyon 1, IFR128-Biosciences Gerland, 21 avenue Tony Garnier, 69 007
LYON cedex 07, France
2 CEA, Laboratoire d’Immunochimie, DRDC/ICH, INSERM U 548, CEA-Grenoble, 17 rue des
martyrs, F-38054 GRENOBLE CEDEX 9, France
3 Laboratoire de Spectrométrie de Masse Bio-Organique, UMR CNRS 7509, ECPM, 25 rue 3
Becquerel, 67008 STRASBOURG Cedex, France
4 Biologie des Cellules Dendritiques Humaines, INSERM U725, ETS Strasbourg, 10 rue Spielmann ,
67 065 Strasbourg cedex, France
Correspondence :
Thierry Rabilloud, DRDC/ICH, INSERM U 548
CEA-Grenoble, 17 rue des martyrs,
F-38054 GRENOBLE CEDEX 9
Tel (33)-4-38-78-32-12
Fax (33)-4-38-78-51-87
e-mail: Thierry.Rabilloud@cea.fr
Abbreviations:
DC, dendritic cells, LPS: lipopolysaccharide , MHC: major histocompatibility complex, MnSOD:
manganese superoxide dismutase, OxLDL: oxidized low-density lipoprotein , Prx: peroxiredoxin
Abstract
Dendritic cells (DC) displays the unique ability to activate naive T cells and to initiate primary T-cell
responses revealed in DC – T cell alloreactions. DC frequently operate under stress conditions.
Oxidative stress enhances the production of inflammatory cytokines by DC. We performed a proteomic
analysis in order to see which major changes occur, at the protein expression level, during DC
differentiation and maturation. Comparative 2D gel analysis of the monocyte, immature DC and
mature DC stages were performed. Manganese superoxide dismutase (MnSOD), reaches 0.7% of the
gel-displayed proteins at the mature DC stage. This important amount of MnSOD is a primary
antioxidant defence system against superoxide radicals, but its product, H2O2, is also deleterious for
cells. Peroxiredoxin enzymes (Prx) play an important role in eliminating such peroxide. Prx1
expression level continuously increases during DC differentiation and maturation while Prx6
continuously decreases and Prx2 peaks at the immature DC stage. As a consequence, DC are more
resistant than monocytes to apoptosis induced by high amounts of oxidized low-density lipoproteins
(oxLDL) containing toxic organic peroxides and hydrogen peroxide. Furthermore, DC-stimulated T
cells produce high levels of receptor activator of nuclear factor B ligand (RANKL), a chemotactic and
survival factor for moncocytes and DC. This study provides insights into the original ability of DC to
express very high levels of antioxidant enzymes such as MnSOD and Prx1, to detoxify oxLDL and to
induce high levels of RANKL by the T cells they activate, and further emphasizes the role that DC
might play in atherosclerosis, a pathology recognized as a chronic inflammatory disorder.
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 1-Introduction
Dendritic cells (DC) are the most potent antigen-presenting cells (APC) in the body, and their unique
ability to stimulate a primary T-cell response places them at the centre of the immune response [1].
Immature DC differentiate from bone marrow progenitors or from monocytes and then either stay in
the blood stream or migrate in the peripheral tissues. Immature DC, such as Langerhans cells in the
skin, survey incoming pathogens. They are equipped with receptors to become activated when exposed
to pathogen associated molecular patterns (PAMP) [2]. Their capacity to recognize pathogens and
become activated therefore represents the first critical event in the initiation of the immune response.
Encounter with a pathogen leads to DC maturation and migration through lymphatic vessels to T cell
area of secondary lymphoid organs. Antigen presentation by DC activates specific naive T cells to
express CD40 ligand (CD154) [3], which, in turn, activates DC, achieving their terminal
differentiation, as assessed by the up-regulation of MHC-I and II molecules and of co-stimulatory
molecules CD80/CD86 and by the production of cytokines, such as IL-12 and IL-1α/β, which all
participate in T cell stimulation [3-5] and in the development of adaptive immunity [4], [6]. Mature DC
modulate T-cell responses through the secretion of various cytokines such as IL-12, promoting Th1-
type cellular immune response [7] or IL-4 following thymic stromal lymphopoietin activation,
promoting Th2-type humoral immune response  [8]. Last, a DC apoptosis program can be triggered at
the end of the maturation process, so that mature DC do not produce an over stimulation of the immune
system [9].  DC frequently operate under stress conditions induced by tissue damage, infectious
pathogens or inflammatory reactions. Oxidative stress enhances the production of inflammatory
cytokines by DC [10].
Atherosclerosis is considered as a chronic inflammatory disease of the arterial vasculature, initiated by
endothelial cell damage and implicating both monocytes, DC and macrophages that operate under
intense oxidative stress conditions. Indeed, the accumulation of oxidized low-density lipoproteins
(oxLDL), generated from native LDL trapped into the subendothelial space of the arterial wall, is a
main feature of the disease and plays a key role in its progression, leading to the formation of vascular
lesions [11], [12]. This accumulation of oxLDL induces the activation of macrophages and elicits an
oxidative burst [13], generating toxic components such as the superoxide anions, derived from the
NADPH oxidase activity. Lipid peroxides and hydrogen peroxide directly contained in oxLDL are also
toxic per se [14]. Due to their pro-oxidant actions, superoxide anions resulting from macrophage
activation by oxLDL, as well as lipid peroxides contained in the oxLDL, are able to induce resident
monocytes and macrophages apoptosis [14-16]. This apoptosis is a commun feature within early
atherosclerotic lesions [17]. Superoxide anions can be reduced into H2O and O2 by combination of the
actions of cellular superoxide dismutase (SOD) and peroxiredoxin (Prx) or catalase or other
peroxidases. Thus, it is hypothesized that monocytes and macrophages undergo apoptosis when their
antioxidant enzymatic protection systems (SOD and Prx) are overflowed. Contrary to monocytes and
macrophages, the expression pattern of  oxidative stress response proteins in DC is still unknown.
Although both immature and mature DC have been observed in the atherosclerotic plaques in close
association with activated T cells [18], and in para-aortic and jugulodigastric lymph nodes attached to
atherosclerotic arterial wall [19], their exact role in atherosclerosis progression is still poorly
understood. These studies however suggest that vascular DC may be implicated in the local induction
of immune and auto-immune reactions [20], [21].
Besides their toxic action on diverse cell types, OxLDL also increase monocyte adhesion to the
endothelial cell layer, as well as their transmigration [22-24] towards adjacent tissues. Finally oxLDL
trigger the production of pro-inflammatory cytokines such as monocyte chemoattractant protein-1
(MCP-1), M-CSF, and granulocyte macrophage colony-stimulating factor (GM-CSF) by endothelial
cells and stimulate monocyte differentiation into DC [25].
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Here we investigated the relationship between oxidative stress protein expression profiles and DC
differentiation and maturation. We performed a proteomic analysis of both immature and mature DC
derived from monocytes in the presence of IL-4 and GM-CSF and compared it to monocyte proteome.
This comparative proteomic approach revealed the original ability of DC to express high levels of
antioxidant enzymes such as MnSOD and Prx. These high expression levels of antioxydant enzymes
confer a great capacity to DC to resist to apoptosis induced by oxLDL, mimicking the oxidative stress
microenvironment of atherosclerosis lesions. Moreover, when co-cultured with T cells, DC produce
themselves, and induce T cells to produce, high levels of receptor activator of NF-κB ligand (RANKL),
a chemotactic factor for monocytes and a key survival factor for DC [26-28]. Altogether, these in vitro
results suggest that DC play a crucial role in the atherosclerosis pathogenesis and in the maintenance of
its chronicity.
2-Materials and methods
Cell culture and reagents
Monocytes and T cells were purified [29] from the adult blood of healthy volunteer donors
(Etablissement français du sang, Lyon Gerland, France). Monocyte-derived DC were generated in
vitro, as previously described [29]. Briefly, monocytes were seeded at 106 cells/mL and maintained in
RPMI 1640 (Life Technologies, Paisley, Scotland) supplemented with 10 mM Hepes, 2 mM L-
glutamine, 40 µg/mL gentamicin (Life Technologies), 10% heat-inactivated FCS (Boehringer
Mannheim, Meylan, France), 50 ng/mL hrGM-CSF and 500 U/mL hrIL-4. After 6 days of culture,
more than 95% of the cells were DC as assessed by CD1a labelling. Recombinant human GM-CSF and
IL-4 were purchased from PeproTech (Rocky Hill, New Jersey). For maturation, immature DC were
plated at 106 cells/ml and were stimulated with 1 µg/mL LPS or with 105/ml irradiated (7,000 rads)
fibroblastic CD40L- or control CD32- transfected L cells (both kindly provided by Schering-Plough
Laboratory for Immunological Research, Dardilly, France) for 24h. For OxLDL cultures, 10%
lipoprotein-deficient FCS (Sigma-Aldrich) was used. T cell activation was performed at 106 cells/mL
with 1µg/mL anti-CD3 (HIT3a murine mAb) and 10µg/mL anti-CD28 (CD28.2 murine mAb) from
PharMingen (California). For proteomic studies, cells were harvested by centrifugation, rinsed in PBS
and resuspended in homogeneization buffer (0.25 M sucrose, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA).
A buffer volume approximately equal to the packed cell volume was used. The suspension was
transferred to a polyallomer ultracentrifuge tube and the cells were lysed by the addition of 4 volumes
(respective to the suspension volume) of 8.75 M urea, 2.5 M thiourea, 25 mM spermine base and 50
mM DTT. After 1 hour at room temperature, the extracts were ultracentrifuged (30 minutes at
200000g). The supernatant was collected and the protein was determined by a Bradford assay, using
bovine serum albumin as a standard. Carrier ampholytes (0.4 % final concentration) were added and
the protein extracts were stored at -20°C.
Human Prx2 was purified from freshly isolated human red blood cell by ion-exchange chromatography
and gel filtration, as previously described  [30].
LDL preparation
LDL (1.025 ≤ density ≤ 1.055 g/ml) was isolated from human plasma of normolipidemic healthy
individuals by ultracentrifugation, as described previously [25]. The protein content of LDL was
estimated by Coomassie Protein MicroAssay procedure (Pierce, Rockford, IL), and its lipid
composition was determined using cholesterol RTU, triglycerides enzymatic PAP 150, and
phospholipids enzymatic PAP 150 kits from bioMérieux (Marcy l’Etoile, France).
LDL oxidation
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LDL concentration was adjusted at 1 mg/ml of protein by dilution in PBS and dialyzed at 4°C against
PBS to eliminate EDTA. Cu2+-mediated oxidation was conducted at 37°C for 24 h by dialysis against
5 µM CuSO4/ PBS. The reaction was stopped by addition of 40 µM butylated-hydroxytoluene and
extensive dialysis at 4°C against PBS containing 100 µM diethylendiamine pentaacetic acid.
Flow cytometry.
Cell suspensions were labelled according to standard procedures using the following monoclonal
antibodies: CD1a-PE, CD14-PE, CD25-PE, CD80-FITC, CD83-PE, CD86-PE, MHC I (HLA-ABC-
FITC), MHC II (HLA-DR-FITC) or an isotype control (Beckman Coulter, Villepinte, France). 0.5
µg/mL of propidium iodide were added to detect apoptotic cells. Immunostaining was performed in 1%
BSA and 3% human serum-PBS and then quantified on a FACSCalibur (Becton Dickinson, Pont de
Claix, France).
Immunofluorescence staining.
Cells cultured on glass coverslips were first fixed for 10 min with 3.7% formaldehyde in phosphate
buffered saline (PBS) and permeabilized with 0.1% Triton X-100 in PBS for 7 min. After pre-
incubation for 20 min in normal human serum with 10% PBS, cells were incubated with anti-RANKL
(sc-9073 rabbit polyclonal Santa-Cruz) and anti-CD3 (UCHT1 mAb Beckman Coulter) antibodies.
Coverslips were then treated with the appropriate conjugated secondary antibodies (donkey anti-rabbit
or donkey anti-mouse antibodies, Jackson ImmunoResearch). Primary and secondary antibodies were
applied for 60 min, in a humidified chamber. Between each step, coverslips were washed three times
for 5 min in PBS buffer. Observations were performed by epifluorescence using a Zeiss axioplan
microscope.
Allogeneic T cell stimulation.
DC were cultured in various numbers (10 to 105), for 7 days, in the presence of a constant number of T
cells (105 cells / well) purified from the blood of another donor (allogeneic), as previously described
[31]. [3H] Thymidine incorporation was measured after a 12h pulse with 1 µCi [3H]TdR/ well, using a
Top Count NXT counter (Packard Bioscience, PerkinElmer Life Sciences, France).
Western blots
Cells were lysed in a buffer containing 200 mM NaCl, 40 mM Tris–HCl pH 8.0, 1% NP-40 2 mM
EDTA, 1mM PMSF, 1mM NaF, 10µg/mL aprotinin and a mixture of protease inhibitors (protease
inhibitor set III, Calbiochem, Darmstadt, Germany) for 15 min at 4°C. Insoluble materials were
removed by centrifugation at 10 000 g for 10 min. Proteins from cell lysates were separated by
SDS–PAGE using NuPAGE 4-12% Bis-Tris Gel (Invitrogen, Cergy Pontoise, France), then transferred
to Immobilon-P membranes (Millipore, Bedford, MA). Membranes were blocked using 5% BSA in
TBS-T (20 mM Tris (pH 7.6), 130 mM NaCl, and 0.1% Tween 20) and incubated for 1 h with a
specific anti-MnSOD antibody (#06-984, Upstate cell signaling solutions, Charlottesville, VA).
Immunoreactive bands were visualized by using a secondary goat anti-rabbit HRP-conjugated antibody
(Jackson ImmunoResearch, West Grove, PE) and chemiluminescence (ECL Western Blotting Substrate
Kit, Pierce, Rockford, IL). The membranes were not stripped before reblotting with anti-actin antibody
(A-2066, Sigma-Aldrich Chimie, Saint Quentin Fallavier, France).
Two-dimensional electrophoresis
Two-dimensional electrophoresis was performed with immobilised pH gradients for isoelectric
focusing. Home-made linear 4-8 or 4-12 gradients were used [32] and prepared according to published
procedures [33]. IPG strips were cut with a paper cutter, and rehydrated in 7M urea, 2M thiourea, 4%
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CHAPS, 0.4% carrier ampholytes (3-10 range), containing either 20mM DTT (4-8 gradients) or 5mM
Tris cyanoethyl phosphine (purchased from MolecularProbes, for 4-12 gradients) [34]. The protein
sample was mixed with the rehydration solution in the case of 4-8 gradients, or cup-loaded at the anode
for 4-12 gradients. Isoelectric focusing was carried out for a total of 60000 Vh. After focusing, the
strips were equilibrated for 2 x 10 minutes in 6M urea, 2% SDS, 125 mM Tris-HCl pH 7.5 containing
either 50mM DTT (first equilibration step) or 150mM iodoacetamide (second equilibration step). The
equilibrated strip was loaded on the top of a 10% or 11% polyacrylamide gel, and submitted to SDS
PAGE at 12W/ gel, using the Tris-taurine system [35].
After migration, the gels were stained either with silver nitrate for 2D gels with a pH 4-8 gradient [36].,
or with ammoniacal silver for 2D gels with a pH 4 to 12 gradient [37].  Quantitative gel analysis was
performed on the silver-stained gels with the Melanie II software (Genebio, Geneva, Switzerland). The
experiments were performed in triplicate, starting with different cell batches. Several gels were made
for each culture, in order to select gels with very close detection signal levels for quantitative analysis.
This allowed us to keep the gel analysis parameters constant for better reproducibility. As a matter of
facts, the total spot intensity in the analyzed gels ranged from 531400 to 662750 arbitrary absorbance
units, with a mean of 600290 units, i.e. a maximum deviation of ±11%.
Mass spectrometry
In gel digestion :
Excised gel slice rinsing was performed by the Massprep (Micromass, Manchester, UK) as described
previously [38]. Gel pieces were completely dried with a Speed Vac before digestion. The dried gel
volume was evaluated and three volumes trypsin (Promega, Madison, US) 12.5ng/µl freshly diluted in
25mM NH4HCO3, were added. The digestion was performed at 35°C overnight. Then, the gel pieces
were centrifuged for 5 min in a Speed Vac and 5µl of 35% H2O/ 60% acetonitrile/ 5% HCOOH were
added to extracted peptides. The mixture was sonicated for 5 min and centrifuged for 5 min. The
supernatant was recovered and the procedure was repeated once.
MALDI-TOF-MS analysis
Mass measurements were carried out on an ULTRAFLEX™ MALDI TOF/TOF mass spectrometer
(Bruker-Daltonik GmbH, Bremen, Germany).This instrument was used at a maximum accelerating
potential of 20kV and was operated either in reflector positive mode. Sample preparation was
performed with the dried droplet method using a mixture of 0.5mL of sample with 0.5mL of matrix
solution. The matrix solution was prepared from a saturated solution of α-cyano-4-hydroxycinnamic
acid in H2O/ 50% acetonitrile diluted 3 times. Internal calibration was performed with tryptic peptides
resulting from autodigestion of trypsin (monoisotopic masses at m/z=842.51 , m/z=1045.564 , m/z=
2211.105).
MS Data analysis
Monoisotopic peptide masses were assigned and used for databases searches using the search engines
MASCOT (Matrix Science, London, UK) [39], and Aldente (www.expasy.org). All proteins present in
Swiss-Prot were used without any pI and Mr restrictions. The peptide mass error was limited to 90
ppm, one possible missed cleavage was accepted.
MS/MS data analysis
(LC-MS-MS) analysis of the digested proteins were performed using a CapLC capillary LC system
(Micromass, Manchester, UK) coupled to a hybrid quadrupole orthogonal acceleration time-of-flight
tandem mass spectrometer (Q-TOF II, Micromass). The LC-MS union was made with a PicoTip (New
Objective, Woburn,.MA) fitted on a ZSPRAY (Micromass) interface. Chromatographic separations
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were conducted on a reversed-phase (RP) capillary column (Pepmap C18, 75µm i.d., 15 cm lenght, LC
Packings) with a 200 nL/min flow. The gradient profile used consisted of a linear gradient from 95% A
(H2O / 0.05% HCOOH) to 45% B ( acetonitrile / 0.05% HCOOH) in 35 min. followed by a linear
gradient to 95% B in 1 min. Mass data acquisitions were piloted by MassLynx software (Micromass,
Manchester, UK) using automatic switching between MS and MS/MS modes. The internal parameters
of Q-TOF II were set as follows. The electrospray capillary voltage was set to 3.0 kV, the cone voltage
set to 30 V, and the source temperature set to 80°C. The MS survey scan was m/z 300-1500 with a scan
time of 1 s and a interscan time of 0.1s. When the intensity of a peak rose above a threshold of 8
counts, tandem mass spectra were acquired. Normalized collision energies for peptide fragmentation
was set using the charge-state recognition files for +1, +2 and +3 peptides ions. The scan range for
MS/MS acquisition was from m/z 50 to 1500 with a scan time of 1 s and a interscan time of 0.1s.
Fragmentation was performed using argon as the collision gas and with a collision energy profile
optimized for various mass ranges of precursor ions.
Mass data collected during a nanoLC-MS/MS analysis were processed and converted into a .PKL file
to be submitted to the search software MASCOT (Matrix Science, London, UK).
Statistics
Statistical comparisons were made using the Student’s two tailed t test. All results are representative of
at least 3 experiments and expressed as means ± SD of at least 3 replicates.
3-Results
Human monocyte-derived DC are classically CD1a+ and CD14-, opposite to monocytes. The immature
DC phenotype was attested by intermediate surface expression levels of HLA-ABC and HLA-DR and
by negative or low expression of CD25, CD83 and co-stimulatory molecules CD80, CD86 (Fig. 1a).
Following stimulation by the bacterial-derived danger signal LPS or by the T cell-derived signal CD40-
ligand, DC phenotype displayed the typical inductions of CD25, CD83 and enhancements of CD80,
CD86, HLA-ABC and HLA-DR surface expressions. DC differed from monocytes in their function
since they elicited allogeneic T-cell responses (Fig. 1b).
Comparative 2D gel analysis of the monocyte, immature DC and mature DC stages is shown on figures
2 and 3. The most striking and reproducible differences indicated by arrows on the figures, as pulled
out from a quantitative gel image analysis, were further analyzed by mass spectrometry to determine
the nature of these differentially-expressed proteins. Gels with close detection sensitivity were selected,
so that the detection parameters for image analysis could be kept constant and lead to close quantitative
values (see methods section). It is striking to note that there are relatively few reproducible differences,
especially between immature and mature dendritic cells. This step was our initial main focus, as the
monocyte-immature dendritic cell transition had been investigated before [40]. These few differences
point to well known functions of dendritic cells, such as antigen presentation (HLA class II), or
cytokine production (IL1). They also point out cytoskeletal remodelling (gelsolin), which is obvious
when taking into account the morphological changes between monocytes, immature and mature
dendritic cells. However, one of the most striking diffferences is MnSOD. This protein has been
previously described as heavily induced during the monocyte-immature DC transition [40], and it is
rather surprising to see that despite the high levels reached at this stage, a further induction is observed
during DC maturation. As MnSOD is an oxidative stress response protein, which expression is often
modulated during pro-apoptotic conditions [41] or during cancer transformation [42], this oriented us
to focus our study on oxidative stress response proteins. This was further reinforced by the fact that
Prx1, which is also an important oxidative stress response protein, and Trx1, which plays an important
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role in several cellular redox processes, were also shown to be induced at both stages, as MnSOD.
An additional benefit of the proteomics approach in the study of peroxiredoxins is that this technology
allows the access to both native and oxidized forms of the proteins [43], [44]. From previously
mentioned studies, we knew the positions of the various peroxiredoxins spots on the gels. We however
reassessed their positions on our DC gels by mass spectrometry to further secure our identifications.
Sequence coverages were always above 50% (data not shown), thereby providing safe protein
identifications. The identification of the peroxiredoxins and of Mn SOD was however also secured by
MS/MS analysis (see supplementary material)
The quantitative results obtained on oxidative stress proteins are summarized in Table 1.  Although
they were identified on the gels as very minor spots (indicated by arrowheads), the oxidized forms of
Prx1, Prx2 and Prx6 are not mentioned in the table, as they did not show any quantitative variation
along DC differentiation and maturation processes. Expressions of the various proteins belonging to the
Prx family are divergent and depend on the differentiation and maturation states. Some Prx decreased
moderately but steadily during the differentiation and maturation process (Prx6, Prx4), while others
increased steadily (Prx1), and others showed a bell-shaped expression curve (Prx2), peaking at the
immature DC stage. The low but steady expression level of the mitochondrial Prx3 is surprising, as it is
a mitochondrial oxidative stress response protein (as MnSOD). However, MnSOD is expressed at
much higher levels and also shows a clear induction in our biological system. Finally, results similar to
those obtained with CD40-ligand were also obtained upon DC maturation with LPS (data not shown).
In  order to confirm those results, we used two different strategies. One is a co-migration strategy (Fig.
4). Pure Prx2 purified from human red blood cells [30] was added in increasing amounts to monocytes
extracts, and the spiked extracts were separated by two-dimensional electrophoresis and submitted to
image analysis. The results obtained showed a two-fold difference between the amount of Prx2 that
should be added to mimic the intensity observed in DC (e.g. 20ng for immature DC) and the amount
that was deduced from the quantitative image measurements (theoretically 40 ng).  This can be
accounted for by postulating that half of the loaded proteins are lost in the 4-8 two-dimensional
analysis, either from proteins lying outside the separation space (in pI and Mw) or from proteins lost
because of poor solubility (e.g. membrane proteins). Such a quantitative yield has already been
described [45]. The second strategy is western blotting, and was used for MnSOD (Fig.5). SDS-PAGE
gels were used to secure against any artefact arising from 2D electrophoresis. The results clearly show
an induction of the protein, as observed from 2D gels. However, the induction factors observed by
blotting were clearly inferior to those observed by 2D gel electrophoresis, in accordance with the
known non linear behavior of western blotting [46].
Due to their high rate of anti-oxidant enzymes, we postulated that DC are more resistant to oxidative
environments than monocytes. In human advanced atherosclerosis, the atherosclerotic lesions (plaques)
constitute an extensive oxidative environment. Indeed, oxLDL accumulating in these lesions, trigger
the production of superoxide and peroxide by macrophages, but also directly exert a toxic activity
towards different cell types, because of the lipid peroxides and hydrogen peroxide they contain. In vitro
experiments have previously revealed that oxLDL are toxic and apoptosis-inducing for macrophages
and smooth muscle cells [15], [47]. We thus studied and compared the survival capacities of both DC
and monocytes exposed to high concentration of oxLDL. Cell death was measured after 24h of
incubation by intracellular incorporation of propidium iodide.. The number of apoptotic monocytes
following oxLDL treatment dramatically increased in the presence of oxLDL from 12% to 76% (Fig.
6a). A preliminary dose response study showed that monocytes were as potent as DC to detoxify
oxLDL until a 50µg/mL concentration (30 to 35% of death). When oxLDL concentration exceeded this
50µg/mL threshold, more than 87,3% of monocytes underwent apoptosis while immature DC and
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mature DC were less affected (47,8 and 67,3% of death respectively) (Fig. 6b). More detailled
investigations, working with 75µg/mL oxLDL doses demonstrated that immature DC and, to a lower
extent, mature DC were more resistant than monocytes to the apoptosis induced by high doses of
oxLDL (Fig. 6c). Thus the survival of immature DC in the oxidative stress environment generated by
oxLDL in vitro is better than monocyte survival. This finding can be correlated to  their respective
expression levels of MnSOD and Prx.
The enhanced capacity of immature DC to survive in an oxLDL-enriched environment, compared to
monocytes, as well as the presence of DC-associated T cells in atherosclerosis lesions, lead us to
investigate the production of RANKL in DC/Tcell co-cultures. RANKL is the ligand of the TNF
receptor family member RANK, expressed on T cells activated by anti-CD3 and anti-CD28 antibodies
[48] and on memory T cells [27]. It is a crucial survival factor for DC and a chemotactic factor for
monocytes [26], [28], [49]. Moreover, RANK and RANKL expressions have reported in the
atherosclerotic plaques [50]. Immunofluorescent staining were used to study the expression of RANKL
on T cells co-cultured with monocytes or DC. T cells co-cultured with monocytes weakly expressed
RANKL and monocytes did not express RANKL themselves. In contrast, T cells co-cultured for 5 days
with DC strongly expressed RANKL on their surface. Interestingly, DC also displayed RANKL
expression (Fig. 7). Consequently besides MnSOD and Prx overexpressions, DC-induced RANKL
expression may also be a key parameter accounting for a role of DC in atherosclerosis pathogenesis.
4-Discussion
Because of their outstanding interest in immunology, gene expression in DC has been studied in
details, both at the monocyte-immature DC transition [40], [51], and at the immature-mature DC
transition [52], [53]. Proteomic study complementing the latter transcriptomic studies on DC
maturation was required. We focussed our study on a major protein induction observed in proteomics:
MnSOD reaches (by combining the two major MnSOD spots) 0.7% of the gel-displayed proteins at the
mature DC stage. This important amount oriented us to study the oxidative stress response pathways.
MnSOD is up-regulated by a variety of pro-inflammatory mediators, such as TNF- α, LPS, IL-1β and
IFN-γ [54], [55]. Therefore, the observed induction of MnSOD protein can be correlated with its well-
documented role as an anti-apoptotic protein [41], [56]. The main activity of MnSOD enzyme is to
reduce anion superoxides into hydrogen peroxides. Together with glutathione peroxidase and catalase,
Prx enzymes play an important role in eliminating peroxides [57], which are produced by numerous
pathways, including the dismutation of superoxide. For example, Prx1 and Prx2 are involved in the
removal of H2O2 in thyroid cells and can protect these cells from undergoing apoptosis [58]. Only a
moderate increase of DC apoptosis was observed in the presence of H2O2, [59] probably due to their
high Prx expression. Strikingly, H2O2 rather seems to be an activating signal for DC, as it stimulates
their production of IL-8 and TNF-α in a dose-dependent manner [10].
The high amount of antioxidant enzymes awards DC the ability to survive in highly oxidant
environment. This also correlates with the anti-apoptotic effects observed upon DC maturation [60].
Recent studies demonstrated that oxLDL promote DC differentiation from monocytes [25], whereas
oxLDL induce apoptosis of human macrophages, a main feature in the first steps of atherogenesis [61].
As oxLDL produce both organic peroxides and hydrogen peroxide [14], it was interesting to study the
changes in Prx expression during DC differentiation and maturation. In this case, the proteomic study
is especially well-suited, as the native and oxidatively-inactivated forms of Prx can be separated on 2D
gels [43], [44]. In the case of DC differentiation and maturation, we did not notice any changes in these
oxidized forms, which were present at very low amounts. However, interesting quantitative findings
could be made on the normal forms of Prx. First of all, the relative amounts of the various Prx are very
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different. Mitochondrial Prx3 was always expressed at low levels. However, among the cytosolic Prx
(Prx1, 2 and 6), Prx2 is expressed at much lower level than Prx1 or Prx6 in monocytes (350 versus
above 2000 ppm), while this is not the case in Jurkat cells (where Prx6 is almost undetectable [43]) or
in HeLa cells, where Prx2 is expressed at much higher levels [44]. Prx2 counteracts the NF-κB
pathway [57], required for DC maturation [60]. It is therefore not surprising to find low levels of Prx2
in mature DC and, more generally, low levels of Prx2 in the monocyte-DC lineage compared to other
haematopoietic lineages [62].
It is generally believed that all mammalian cytosolic peroxiredoxins have similar substrate specificity
and are thus able to destroy both hydrogen peroxide and organic peroxides [63].  In terms of peroxide
destruction, the total cytosolic peroxiredoxin amount (i.e. Prx1 + Prx2 + Prx6) increases from 4800
ppm at the monocyte stage to 7500 ppm at the immature DC stage and to 9300 ppm at the mature DC.
Although Prx6 also exhibit other different actions, which may alter this simplistic scheme, our results
suggests that the Prx defence line is induced steadily during the DC differentiation and maturation.
This overall increase, however, masks divergent quantitative changes in the cytosolic peroxiredoxins
upon DC differentiation and maturation, which is the most surprising part of our data. Prx1
continuously increases during this process (close to 3 fold) while Prx6 continuously decreases (2 fold)
and Prx2 peaks at the immature DC stage.
An interesting trend is provided by the dual function of Prx6, which is at the same time a peroxiredoxin
and a phospholipase A2 (PLA2) [64]. Thus, a decrease in Prx6 amount also means a decrease in PLA2
activity. Easily oxidized polyunsaturated fatty acids are often found at the 2-position in phospholipids,
and are therefore liberated by PLA2 activity. Inhibition of PLA2 can be of physiological interest since
it prevents the rise of lysophosphatidylcholine levels and diminishes the death-inducing effects of
oxLDL on monocytes [65]. Apart from the context of oxidized lipids, it must be kept in mind that Prx6
is also an activator of NADPH oxidase [66], which is active in DC and especially mature ones [67]. All
these factors may explain the reorientation from Prx6 to Prx1, occurring during DC differentiation and
maturation.
In a more general frame, our data concerning monocytes and DC survival in an oxLDL-enriched stress
environment can not be directly correlated to the global cellular expression levels of anti-oxidant
enzymes Prx.  Indeed, mature DC, which have the highest contents in Prx, are more sensitive to
oxLDL-induced apoptosis than immature DC. Cell survival to oxLDL-induced death correlates rather
well with the cytosolic amount of Prx-2. This is rather surprising, as the various mammalian Prx are
known to be able to reduce the same scope of peroxides in vitro [63]. However, it must be kept in mind
that Prx interact with multiple and different partners [68]. These other interactions may alter their
operational efficiency, either by altering their catalytic efficiency or by segregating some types of Prx
away from the peroxide substrates generated by oxLDL, expecially lipid hydroperoxides. This may
explain why reistance to oxLDL correlates with the expression of one particular Prx and not with the
total Prx amount.
Concerning the role of DC in atherosclerosis, it is now accepted that mature DC, which are known to
be present in advanced plaques [69], contribute to plaque destabilization especially through T cell
activation and CD40–CD40L interactions play a key role in atherosclerosis progression [70]. Besides
being implicated in the induction of local immune  or auto-immune responses,  our results indicate, that
when interacting with T cells,  DC produce the cytokine RANKL themselves and induce its production
by T cells. RANKL, also called osteoprotegerin-ligand (OPGL) or TNF-related activation-induced
cytokine (TRANCE), is a chemotactic factor for monocytes, together with MCP-1 produced by
endothelial cells, following oxLDL stimulation in atherosclerosis. RANKL expression has been
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detected in advanced calcified lesions of atherosclerosis [50]. Thus DC and T cell-derived RANKL
might also enhance the recruitment of monocytes from blood towards the atherosclerosis lesions.
RANKL also plays important roles in DC homeostasis. RANKL-RANK interaction has been shown to
sustain DC survival, by inducing the anti-apototic gene Bcl-xL [28]. Skin CD1a+ DC express RANK
but lack RANKL and are short-lived. However, they can be rescued from cell death, either by
recombinant soluble RANKL or by RANKL+ DC generated in vitro from CD34+ progenitors [28]. In
addition to enhancing DC survival, RANKL induces the expression of proinflammatory cytokines (IL-
6, IL-1) and T cell growth and differentiation factors (IL-12, IL-15) by DC in vitro [27]. RANKL also
provides co-stimulation required for efficient CD4+ T cell priming during viral infection in the absence
of CD40L/CD40 [49], [71]. These data further suggest that, besides recruiting more monocytes to the
atherogenic plaque, RANKL produced locally may also increase DC lifespan in the plaque and amplify
their functions, then contributing to the progression of atherosclerosis.
In conclusion, DC recruitment, maturation and survival may be critical factors for the progression of
atherosclerosis: (i) DC recruitment into the vascular wall is increased by atherogenic stimuli such as
oxLDL, TNF-α, and hypoxia [72], (ii) DC maturation is induced by different atherogenic stimuli such
as superoxide, oxLDL, lysophosphatidylcholine, nicotine, angiotensin II, atrial natriuretic peptide, and
TNF-α [7-10], [73], [74] (iii) DC survival in the atherosclerotic plaque environment is a third
important factor enabling these professional antigen presenting cells to induce a more important
antigen-specific T cell activation. The high anti-oxidant enzyme expression levels, the better resistance
to oxLDL-induced apoptosis and the production of RANKL upon DC/T cell interactions, that we
highlighted in this work are three elements which further implicate DC in the pathogenesis of
atherosclerosis and emphasize the role they may play in the amplification of the chronic inflammation,
together with hypercholesterolemia and oxidative stress. This role of DC in atherosclerosis progression
was recently further supported by  observations indicating that oxLDL and platelet-activating factor
contained in the lesions locally activate DC, but inhibit their migration to draining lymph nodes [75].
This activated-DC sequestration, in addition to enhanced DC survival, may further aggravate the local
inflammation.
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Figure legends
Figure 1: Phenotype and function of human monocytes and DC.
(A) Phenotype analysis of peripheral blood monocytes (dashed line), monocyte-derived immature DC
(thick line) and CD40L-activated mature DC (bold line) by cytofluorimetry. Cells were stained with
antibodies against CD1a, CD14, CD25, CD80, CD83, CD86, HLA-ABC and HLA-DR or related
isotype control antibodies (gray histogram). Data are representative of more than 10 experiments.
(B) T cell proliferation measured by thymidine incorporation, at indicated time points, in coculture of
allogeneic T cells with either DC (circle) or monocytes (square). DC: T cell ratio was 1:100 cells.
Triplicate experiment is representative of more than 10 experiments.
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Figure 2: 2D electrophoresis of whole cell extracts (acidic and neutral proteins)
Whole cell extracts (120 µg protein) prepared from monocytes, immature and mature dendritic cells
were analysed by 2D electrophoresis. The pH gradient in the first dimension ranged from 4 to 8,
thereby separating the acidic and neutral cellular proteins only. The second dimension was a 10% gel,
using a pH 8 gel and  the taurine system. The oxidative stress response proteins identified on the gels
are shown by arrows. The boxed zone is the one shown in figure 4
Figure 3: 2D electrophoresis of whole cell extracts (basic proteins)
The same analysis as in figure 2 was performed, but a pH 4-12 gradient was used in the first
dimension. The second dimension was a 11% gel, using a pH 8.2 gel and  the taurine system. This
allowed to analyze the basic proteins. Silver staining with ammoniacal silver.
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Figure 4: Comigration of Prx2 with monocyte extracts
Only Prx2 zone is shown in this figure. Increasing amounts of chromatographically purified Prx2 [30]
were added to a monocyte extract, and the spiked extracts were separated by two dimensional
electrophoresis using linear 4-8 pH gradient. A) starting monocyte extract. B) monocyte + 10ng Prx2.
C) monocyte + 20ng Prx2. D) monocyte + 50ng Prx2. E) immature dendritic cells. F) mature dendritic
cells. Arrows points out Prx2 spots in the different conditions.
Figure 5: Western blotting of MnSOD
Western blot analysis of MnSOD expression in monocytes, immature monocyte-derived DC (Imm DC)
and LPS- matured monocyte-derived DC (Mat DC). Immunoblots analysis was performed with anti-
MnSOD antibody (#06-984, Cell Signaling) and anti-actin (A-2066, Sigma Aldrich) antibody as
loading control. Data are representative of two experiments.
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Figure 6: Apoptosis in human monocytes and DC untreated or treated with oxLDL.
Apoptosis was quantified by cytofluorimetry after incorporation of propidium iodide.
(A) Monocytes were cultured 24h with or without 75 _g/mL OxLDL.
(B) Monocytes (diamonds), immature monocyte-derived DC (squares) and CD40L-activated mature
DC was cultured 24h with increasing dose of OxLDL.
(C) Mortality of monocytes, immature monocyte-derived DC and CD40L-activated mature DC was
measured after 24h culture in presence (black bars) or in absence (white bars) of 75 _g/mL OxLDL.
Means and SD of three experiments.
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Figure 7: RANKL expression in cocultures of T cells with either monocytes or DC.
RANKL (green) and CD3 (red) stainings of T cells, after 5 days of culture with (A) monocytes, (B)
immature DC and (C) anti-CD3 plus anti-CD28 antibodies. Stars indicate monocytes (A) or DC (B). T
cells were distinguished from other cells based on CD3 expression and Hoechst nuclei staining (not
shown).
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Table 1: quantitative measurements of the oxidative stress response proteins a, b
Monocytes Immature DC CD40L-activated DC
Mn SOD,
basic spot* 1260±80 ppm 2010±120 ppm 4550±200 ppm
Mn SOD,
acidic spot* 250±30 ppm 1020±80 ppm 2450±180 ppm
Prx1† 2150±100 ppm 4960±240 ppm 7440±460 ppm
Prx2 350±30 ppm 680±40 ppm 520±40 ppm
Prx3 40±15 ppm 50±15 ppm 30±10 ppm
Prx4 850±80 ppm 560±50 ppm 520±40 ppm
Prx6 2240±220 ppm 1810±140 ppm 1350±110 ppm
The values are expressed in ppm of the total spot volume, as calculated by the Melanie software. Due
to the precision of the measurement (typically± 10%, but indicated on the table) they have been
rounded (to the closest decennial)
Study of the variations in expression of the antioxidant proteins between the various cellular stages
showed significant variations (p<0.05) except for Prx3 (no variation), Prx4 between immature and
mature DC (p<0.5), and Prx6 between monocytes and immature DC (p<0.1)
*: Mn SOD can be measured on pH 4-12 and on pH 4-8 gradients. The values are those obtained on pH
4-8 gradients
†:  Prx 1 can be measured only on pH 4-12 gradients. All other Prx are measured on pH 4-8 gradients
